Johnson & Johnson is set to acquire Intra-Cellular Therapies for $14.6 billion.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
J&J set to acquire drugmaker for $14.6B
Johnson & Johnson is set to acquire Intra-Cellular Therapies for $14.6 billion.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis